search
Back to results

Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT

Primary Purpose

Carpal Tunnel Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BEST™ HVPC microcurrent electrical stimulation PRO-SPORT Ultra® Device
Sham PRO-SPORT Ultra® Device
Sponsored by
Avazzia, Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome focused on measuring musculoskeletal disorder, median nerve, carpal tunnel, hand numbness, electric stimulation, microcurrent

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Have a prior diagnosis (Dx) of CTS and have had a trial of conservative treatment for a minimum of 4 weeks without successful results due to continuing symptoms that interfere with normal function.
  • Confirmation of this Dx shall include at least three findings as defined below:

    • Muscle atrophy, severe weakness of thenar muscles
    • 2-point discrimination test >6mm
    • Flick sign (shaking hand)
    • Phalen's sign
    • Tinel's sign
    • Reverse Phalen's sign
    • Abnormal Katz hand diagram scores
    • Positive NCV testing
  • Age >18 - <70 years old
  • Males/Females of all ethnicities
  • Post-surgical failures >6 months post op
  • Ability to understand the informed consent document before signing it

Exclusion Criteria:

  • Systemic disease that would affect treatment outcome such as inflammatory joint diseases (i.e., rheumatoid arthritis, systemic lupus); malignancies undergoing treatment or any malignancies (in remission or not) with involvement of the musculoskeletal system.
  • Co-morbidities, thoracic outlet nerve impingement, neuropathy, etc. should be identified and, if significant, the candidate should be excluded from the study.
  • Cubital tunnel syndrome, anterior and posterior interosseous nerve syndrome, lateral and medial epicondylitis, handlebar palsy, De Quervain's disease, trigger finger, and Intersection syndrome should be differentiated from CTS and not included in this study.
  • Uncontrolled mood disorders, such as depression, anxiety.
  • Drug or substance abuse within past 90 days.
  • Any hand pathology requiring surgical intervention.
  • Active litigation, workers compensation
  • Any participant with an electrically implanted device such as a pacemaker, neural stimulator, etc.
  • Participant is currently pregnant, nursing, or may become pregnant.

Sites / Locations

  • Activated Family Chiropractic and Wellness

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

BEST™ Pro-Sport Ultra® microcurrent device

Electrical Stimulation - Sham Comparator

Arm Description

Participants will receive treatment with an active electrical stimulation device for 7 in-clinic treatments over 2 weeks.

Participants will receive treatment with a sham electrical stimulation device for 7 in-clinic treatments over 2 weeks.

Outcomes

Primary Outcome Measures

Pain Level Assessment
Change in pain associated with CTS during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Pain will be assessed with VAS (Visual Analog Scale pain score) from 0 to 10 where 10 is the worst pain ever.
Motor Function Examination
Change in the score of motor function examination during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed using the motor function score from 0 to 5 where 5 is full range of motion.
Nerve Conduction Velocity
Nerve conduction velocity during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change in nerve conduction velocity will be assessed from the score obtained from testing done by the Mediracer Carpal Tunnel Syndrome Sensory exam from normal to severe.

Secondary Outcome Measures

Healthy Related Quality of Life Changes
Change in health Related Quality of Life during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed with QuickDash score from 0 to 100 where 100 is most severe disability.
Sensory ability changes
Change in sensory ability during visit #1 and 15 [Time Frame: baseline to 5 weeks] Change will be assessed with Katz Hand Diagram.
Dosage/Frequency of Analgesics changes
Change in frequency and dosage of analgesics during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed with comparison of frequency and analgesics from visit to visit.

Full Information

First Posted
January 22, 2020
Last Updated
July 23, 2021
Sponsor
Avazzia, Inc
Collaborators
Joseph Surace, D.C.
search

1. Study Identification

Unique Protocol Identification Number
NCT04271319
Brief Title
Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT
Official Title
Efficacy of a High Voltage Pulsed Current in the Non-Invasive Treatment of Carpal Tunnel Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 14, 2020 (Actual)
Primary Completion Date
August 31, 2021 (Anticipated)
Study Completion Date
August 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Avazzia, Inc
Collaborators
Joseph Surace, D.C.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
A clinical study at Activated Family Chiropractic & Wellness, is being proposed to test the efficacy of a novel electrical stimulation platform named the Pro-Sport Ultra® designed by AVAZZIA to relieve pain and improve mobility in patients with Carpal Tunnel Syndrome (CTS).
Detailed Description
This study will recruit patients with a prior diagnosis (Dx) of CTS and have had a trial of conservative treatment for a minimum of 4 weeks without successful results due to continuing symptoms that interfere with normal function. The primary objective of this study is to compare the changes obtained in CTS that have not successfully responded to non-surgical management by incorporating PRO-Sport Ultra® as opposed to an inactive device. This study aims to compare improvement obtained in CTS using the new therapy. All participants will be randomized into two treatment groups and receive treatment with both active and inactive devices during the study. During the first 2 weeks, one group will receive treatment with the active device and the other group will receive treatment with the inactive device. At the end of week 3 (no treatment week), participants will return to the clinic and will be crossed over for the next 2 weeks of treatment. The Avazzia PRO-Sport Ultra® and BEST-RSI® devices are non-invasive, hand-held, battery operated microcurrent devices that are FDA-cleared for the symptomatic relief and management of chronic, intractable pain and adjunctive treatment in the management of post-surgical and post-traumatic pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome
Keywords
musculoskeletal disorder, median nerve, carpal tunnel, hand numbness, electric stimulation, microcurrent

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Device: Avazzia Pro-Sport Ultra® device High-voltage pulsed current (HVPC) electrical stimulation with Reactions and BEST™ (Bio-Electric Stimulation Technology) microcurrent that measure and change with tissue electrical characteristics.
Masking
ParticipantInvestigator
Masking Description
Double (participant, care provider)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BEST™ Pro-Sport Ultra® microcurrent device
Arm Type
Experimental
Arm Description
Participants will receive treatment with an active electrical stimulation device for 7 in-clinic treatments over 2 weeks.
Arm Title
Electrical Stimulation - Sham Comparator
Arm Type
Sham Comparator
Arm Description
Participants will receive treatment with a sham electrical stimulation device for 7 in-clinic treatments over 2 weeks.
Intervention Type
Device
Intervention Name(s)
BEST™ HVPC microcurrent electrical stimulation PRO-SPORT Ultra® Device
Intervention Description
Participants will receive treatment with an active electrical stimulation device for 7 in-clinic treatments over 2 weeks. Active Avazzia PRO-Sport Ultra® medical device, BEST™ HVPC microcurrent electrical stimulation, FDA cleared for pain relief
Intervention Type
Device
Intervention Name(s)
Sham PRO-SPORT Ultra® Device
Intervention Description
Participants will receive treatment with a sham electrical stimulation device for 7 in-clinic treatments over 2 weeks. Sham PRO-SPORT Ultra® device will be used. The built in electrodes and the accessory port for connecting the lead wire to the electrode pads will be disconnected internal to the device. The device will power on with the same sounds and indications.
Primary Outcome Measure Information:
Title
Pain Level Assessment
Description
Change in pain associated with CTS during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Pain will be assessed with VAS (Visual Analog Scale pain score) from 0 to 10 where 10 is the worst pain ever.
Time Frame
5 weeks
Title
Motor Function Examination
Description
Change in the score of motor function examination during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed using the motor function score from 0 to 5 where 5 is full range of motion.
Time Frame
5 weeks
Title
Nerve Conduction Velocity
Description
Nerve conduction velocity during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change in nerve conduction velocity will be assessed from the score obtained from testing done by the Mediracer Carpal Tunnel Syndrome Sensory exam from normal to severe.
Time Frame
5 weeks
Secondary Outcome Measure Information:
Title
Healthy Related Quality of Life Changes
Description
Change in health Related Quality of Life during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed with QuickDash score from 0 to 100 where 100 is most severe disability.
Time Frame
5 weeks
Title
Sensory ability changes
Description
Change in sensory ability during visit #1 and 15 [Time Frame: baseline to 5 weeks] Change will be assessed with Katz Hand Diagram.
Time Frame
5 weeks
Title
Dosage/Frequency of Analgesics changes
Description
Change in frequency and dosage of analgesics during visit #1, 7, 8 ,14, and visit 15 [Time Frame: baseline to 5 weeks] Change will be assessed with comparison of frequency and analgesics from visit to visit.
Time Frame
5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Have a prior diagnosis (Dx) of CTS and have had a trial of conservative treatment for a minimum of 4 weeks without successful results due to continuing symptoms that interfere with normal function. Confirmation of this Dx shall include at least three findings as defined below: Muscle atrophy, severe weakness of thenar muscles 2-point discrimination test >6mm Flick sign (shaking hand) Phalen's sign Tinel's sign Reverse Phalen's sign Abnormal Katz hand diagram scores Positive NCV testing Age >18 - <70 years old Males/Females of all ethnicities Post-surgical failures >6 months post op Ability to understand the informed consent document before signing it Exclusion Criteria: Systemic disease that would affect treatment outcome such as inflammatory joint diseases (i.e., rheumatoid arthritis, systemic lupus); malignancies undergoing treatment or any malignancies (in remission or not) with involvement of the musculoskeletal system. Co-morbidities, thoracic outlet nerve impingement, neuropathy, etc. should be identified and, if significant, the candidate should be excluded from the study. Cubital tunnel syndrome, anterior and posterior interosseous nerve syndrome, lateral and medial epicondylitis, handlebar palsy, De Quervain's disease, trigger finger, and Intersection syndrome should be differentiated from CTS and not included in this study. Uncontrolled mood disorders, such as depression, anxiety. Drug or substance abuse within past 90 days. Any hand pathology requiring surgical intervention. Active litigation, workers compensation Any participant with an electrically implanted device such as a pacemaker, neural stimulator, etc. Participant is currently pregnant, nursing, or may become pregnant.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joseph Surace, D.C.
Organizational Affiliation
Activated Family Chiropractic & Wellness
Official's Role
Principal Investigator
Facility Information:
Facility Name
Activated Family Chiropractic and Wellness
City
Dallas
State/Province
Texas
ZIP/Postal Code
75240
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT

We'll reach out to this number within 24 hrs